Prospective Study of the Diagnostic and Therapeutic Management of Congenital Glaucoma in France
Conglau
2 other identifiers
interventional
250
1 country
24
Brief Summary
Evidence of a relationship between age at discovery of congenital glaucoma and visual acuity at 4 years of age. The delay in diagnosis is a factor of poor visual acuity. Will justify the implementation of information programs with health and education professionals in order to improve the functional prognosis of patients with congenital glaucoma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2013
Longer than P75 for not_applicable
24 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2013
CompletedFirst Submitted
Initial submission to the registry
March 8, 2017
CompletedFirst Posted
Study publicly available on registry
March 13, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2021
CompletedDecember 3, 2025
December 1, 2025
8.6 years
March 8, 2017
December 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visual acuity by logarithmic scale of Sander-Zanlonghi
Evidence of a relationship between age at discovery of congenital glaucoma and visual acuity at 4 years of age
at 4 years of the child
Secondary Outcomes (1)
Intraocular pressure
at 4 years of the child
Study Arms (1)
TRABECULOTOMY
EXPERIMENTALInterventions
Evaluation of the prognosis of different surgery in congenital glaucoma
Eligibility Criteria
You may qualify if:
- Boys or girls under the age of 4, without antecedent, French or resident in France, Suspected Glaucoma
You may not qualify if:
- Antecedent of surgery for glaucoma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (24)
Chu Amiens Picardie - Amiens 1
Amiens, France
Chu Amiens Picardie
Amiens, France
Centre Hospitalier Regional D' Angers
Angers, France
CHRU Besançon
Besançon, France
CHU Bordeaux
Bordeaux, France
CHU de Clermont-Ferrand
Clermont-Ferrand, France
CHU Dijon Bourgogne
Dijon, France
Chu de Grenoble Alpes
Grenoble, France
CHRU, Hôpital Claude Huriez
Lille, France
Hopital Edouard Herriot - Hcl - Lyon 03
Lyon, 69008, France
Aphm Hopital Nord
Marseille, France
CHRU de Montpellier
Montpellier, France
CHU de Montpellier
Montpellier, France
Centre Hospitalier Universitaire
Nantes, France
Chu de Nice Hopital de L'Archet
Nice, France
Fondation de Rothschild - Paris
Paris, France
Hu Necker Enfants Malades Aphp - Paris 15
Paris, France
Hopital Robert Debre Chu Reims
Reims, France
Chru Rennes Site Pontchaillou
Rennes, France
Hopital Charles Nicolle Chu Rouen
Rouen, France
Hopital Civil / Nouvel Hopital Civil - Strasbourg
Strasbourg, 67091, France
CHU de Toulouse
Toulouse, France
CHRU de Tours
Tours, France
Chu de Tours
Tours, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-François ROULAND, MD, PhD
University Hospital, Lille
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 8, 2017
First Posted
March 13, 2017
Study Start
April 1, 2013
Primary Completion
November 1, 2021
Study Completion
November 1, 2021
Last Updated
December 3, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share